TY - JOUR
T1 - Prediction of arteriovenous fistula clinical maturation from postoperative ultrasound measurements
T2 - Findings from the Hemodialysis Fistula Maturation Study
AU - Hemodialysis Fistula Maturation Study Group
AU - Robbin, Michelle L.
AU - Greene, Tom
AU - Allon, Michael
AU - Dember, Laura M.
AU - Imrey, Peter B.
AU - Cheung, Alfred K.
AU - Himmelfarb, Jonathan
AU - Huber, Thomas S.
AU - Kaufman, James S.
AU - Radeva, Milena K.
AU - Roy-Chaudhury, Prabir
AU - Shiu, Yan Ting
AU - Vazquez, Miguel A
AU - Umphrey, Heidi R.
AU - Alexander, Lauren
AU - Abts, Carl
AU - Beck, Gerald J.
AU - Kusek, John W.
AU - Feldman, Harold I.
N1 - Funding Information:
The HFM study is funded by the National Institute of Diabetes, Digestive and Kidney Disease grants U01DK082179 (to J.H.), U01DK082189 (to T.S.H.), U01DK082218 (to P.R.-C.), U01DK082232 (to L.M.D.), U01DK082236 (to G.J.B.), U01DK082222 (to A.K.C.), and U01DK082240 (to M.A.V.).
Publisher Copyright:
© 2018 by the American Society of Nephrology.
PY - 2018/11
Y1 - 2018/11
N2 - Background: The utility of early postoperative ultrasound measurements in predicting arteriovenous fistula (AVF) clinical maturation is uncertain. Methods: We investigated the relationships of ultrasound parameters with AVF clinical maturation in newly created AVF, measured at 1 day and 2 and 6 weeks, in 602 participants of a multicenter, observational cohort study. A backward elimination algorithm identified ultrasound measurements that independently predicted unassisted and overall AVF maturation. Candidate variables included AVF blood flow, diameter, and depth, upper arm arterial diameter, presence of stenosis, presence of accessory veins, seven case-mix factors (age, sex, black race, AVF location, diabetes, dialysis status, and body mass index), and clinical center. We evaluated the accuracy of the resulting models for clinical prediction. Results: At each ultrasound measurement time, AVF blood flow, diameter, and depth each predicted in a statistically significant manner both unassisted and overall clinical maturation. Moreover, neither the remaining ultrasound parameters nor case-mix factors were associated with clinical AVF maturation after accounting for blood flow, diameter, and depth, althoughmaturation probabilities differed among clinical centers before and after accounting for these parameters. The crossvalidated area under the receiver operating characteristic curve for models constructed using these three ultrasound parameters was 0.69, 0.74, and 0.79 at 1 day and 2 and 6 weeks, respectively, for unassisted AVF clinical maturation and 0.69, 0.71, and 0.76, respectively, for overall AVF maturation. Conclusions: AVF blood flow, diameter, and depth moderately predicted unassisted and overall AVF clinical maturation. The other factors considered did not further improve AVF maturation prediction.
AB - Background: The utility of early postoperative ultrasound measurements in predicting arteriovenous fistula (AVF) clinical maturation is uncertain. Methods: We investigated the relationships of ultrasound parameters with AVF clinical maturation in newly created AVF, measured at 1 day and 2 and 6 weeks, in 602 participants of a multicenter, observational cohort study. A backward elimination algorithm identified ultrasound measurements that independently predicted unassisted and overall AVF maturation. Candidate variables included AVF blood flow, diameter, and depth, upper arm arterial diameter, presence of stenosis, presence of accessory veins, seven case-mix factors (age, sex, black race, AVF location, diabetes, dialysis status, and body mass index), and clinical center. We evaluated the accuracy of the resulting models for clinical prediction. Results: At each ultrasound measurement time, AVF blood flow, diameter, and depth each predicted in a statistically significant manner both unassisted and overall clinical maturation. Moreover, neither the remaining ultrasound parameters nor case-mix factors were associated with clinical AVF maturation after accounting for blood flow, diameter, and depth, althoughmaturation probabilities differed among clinical centers before and after accounting for these parameters. The crossvalidated area under the receiver operating characteristic curve for models constructed using these three ultrasound parameters was 0.69, 0.74, and 0.79 at 1 day and 2 and 6 weeks, respectively, for unassisted AVF clinical maturation and 0.69, 0.71, and 0.76, respectively, for overall AVF maturation. Conclusions: AVF blood flow, diameter, and depth moderately predicted unassisted and overall AVF clinical maturation. The other factors considered did not further improve AVF maturation prediction.
UR - http://www.scopus.com/inward/record.url?scp=85055772653&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055772653&partnerID=8YFLogxK
U2 - 10.1681/ASN.2017111225
DO - 10.1681/ASN.2017111225
M3 - Article
C2 - 30309898
AN - SCOPUS:85055772653
SN - 1046-6673
VL - 29
SP - 2735
EP - 2744
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 11
ER -